ABOUT CAPABILITIES TEAM CAREERS NEWS EVENTS CONTACT NEWS Resilience and Harvard University Announce Five-Year R&D Alliance to Incubate New Technologies, Launch Companies to Advance the Manufacture of Complex Medicines October 15, 2021 Resilience Joins Forces with Children’s Hospital of Philadelphia to Develop Next-Generation Biomanufacturing Technologies, Create Impactful Therapies October 12, 2021 Resilience to Manufacture mRNA for Moderna’s COVID-19 Vaccine September 8, 2021 Bluebird Bio and Resilience Announce Strategic Alliance to Develop Next Generation Cell Therapies July 28, 2021 Resilience Receives USD $164 Million Investment from the Government of Canada to Modernize and Expand Its Ontario Biomanufacturing Site, Improving Pandemic Preparedness May 18, 2021 Resilience Continues Expansion with Acquisition of Biologics Manufacturing Company Ology Bioservices April 12, 2021 How an East Bay site may lead a biotech manufacturing revolution San Francisco Business Times, March 3, 2021 With stars aligned and cash in reserve, Bob Nelsen’s Resilience plans a makeover at 2 new facility additions to its drug manufacturing upstart Endpoints News, March 2, 2021 Resilience Expands North American Capacity with the Acquisition of Two Premier Biologics Manufacturing Facilities March 2, 2021 Fireside Chat with Rahul Signhvi, CEO of Resilience BIO CEO & Investor – February 16, 2021 Resilience bags Sanofi-Genzyme plant in Boston BioProcess International – February 15, 2021 Sanofi prepares to transfer Allston plant to a new company, but not its city tax breaks Boston Globe – February 11, 2021 Raging at the pandemic, a VC raises $800M for a company that aims to transform biotech manufacturing STAT News – November 23, 2020 Resilience Launches to Change the Future of Medicine through Manufacturing Innovation November 23, 2020 CONTACT CONTACT@RESILIENCE.COM 9310 ATHENA CIRCLE LA JOLLA, CA 92037 SITE TEAM CAREERS NEWS EVENTS PRIVACY TERMS © 2021 National Resilience, Inc. All Rights Reserved.